"Etablissement support du Groupement Hospitalier de Territoire (GHT), le Centre Hospitalier de Douai est l’établissement pivot de la zone de proximité du Douaisis. Il assure ses missions de service public hospitalier sur un secteur de 64 communes dont la population rassemble près de 260 000 habitants. Centré sur le patient, l’hôpital porte une attention particulière à l’accueil, à l’accompagnement du patient et de son entourage, à la qualité et à la sécurité des soins, aux modes d’hospitalisation de plus courte durée, ainsi qu’aux prises en charge innovantes."

During the past decade, CH DOUAI conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CH DOUAI" #1 sponsor was "University Hospital, Lille" with 12 trials, followed by "Centre Hospitalier of Chartres" with 2 trials sponsored, "University Hospital, Tours" with 2 trials sponsored, "Centre Hospitalier Universitaire, Amiens" with 1 trials sponsored and "Centre Oscar Lambret" with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CH DOUAI" #1 collaborator was "Ministry of Health, France" with 3 trials as a collaborator, "Région Nord-Pas de Calais, France" with 2 trials as a collaborator, "Air Liquide SA" with 1 trials as a collaborator, "Bordeaux PharmacoEpi" with 1 trials as a collaborator and "CSL Behring" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "CH DOUAI" are "Critical Illness" (2 trials), "Infective Endocarditis" (2 trials), "Suicide, Attempted" (2 trials), "Alzheimer's Disease" (1 trials) and "Antibody Deficiency" (1 trials). Many other conditions were trialed in "CH DOUAI" in a lesser frequency.

Most popular intervention types in "CH DOUAI" are "Other" (10 trials), "Drug" (4 trials), "Procedure" (3 trials), "Behavioral" (2 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Administration of the IPREA3 questionnaire" (2 trials), "Immediate feedback through electronic reminder messages" (2 trials), "Targeted interventions in each ICU to reduce discomforts" (2 trials), "1 year follow-up to assess psychiatric morbidity" (1 trials) and "6 months follow-up to assess the prevalence of PTSD symptoms" (1 trials). Other intervention names were less common.

The vast majority of trials in "CH DOUAI" are 27 trials for "All" genders.

Currently, there are NaN active trials in "CH DOUAI". undefined are not yet recruiting, 7 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in CH DOUAI, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in CH DOUAI, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 11 trials that are defined as “Not Applicable".